Search Results - "Vose, J. M."

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma by Witzig, T.E., Vose, J.M., Zinzani, P.L., Reeder, C.B., Buckstein, R., Polikoff, J.A., Bouabdallah, R., Haioun, C., Tilly, H., Guo, P., Pietronigro, D., Ervin-Haynes, A.L., Czuczman, M.S.

“…Lenalidomide is an immunomodulatory agent with antitumor activity in B-cell malignancies. This phase II trial aimed to demonstrate the safety and efficacy of…”
Get full text

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study by Zinzani, P.L., Vose, J.M., Czuczman, M.S., Reeder, C.B., Haioun, C., Polikoff, J., Tilly, H., Zhang, L., Prandi, K., Li, J., Witzig, T.E.

“…Mantle cell lymphoma (MCL) is an uncommon type of non-Hodgkin lymphoma with poor overall prognosis, requiring the development of new therapies. Lenalidomide is…”
Get full text

Topographic and ecologic controls on root reinforcement by Hales, T. C., Ford, C. R., Hwang, T., Vose, J. M., Band, L. E.

“…Shallow landslides are a significant hazard in steep, soil‐mantled landscapes. During intense rainfall events, the distribution of shallow landslides is…”
Get full text

Inferring the contribution of advection to total ecosystem scalar fluxes over a tall forest in complex terrain by Novick, K., Brantley, S., Miniat, C. Ford, Walker, J., Vose, J.M.

“…•Data from a single tower are used to characterize advection regimes in a new site in complex terrain.•Positive vertical advection was associated with cold-air…”
Get full text

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome by Lechowicz, M J, Lazarus, H M, Carreras, J, Laport, G G, Cutler, C S, Wiernik, P H, Hale, G A, Maharaj, D, Gale, R P, Rowlings, P A, Freytes, C O, Miller, A M, Vose, J M, Maziarz, R T, Montoto, S, Maloney, D G, Hari, P N

“…We describe outcomes after allogeneic hematopoietic cell transplantation (HCT) for mycosis fungoides and Sezary syndrome (MF/SS). Outcomes of 129 subjects with…”
Get full text

Estimates of Precipitation IDF Curves and Design Discharges for Road-Crossing Drainage Structures: Case Study in Four Small Forested Watersheds in the Southeastern US by Amatya, D. M, Tian, S, Marion, D. A, Caldwell, P, Laseter, S, Youssef, M. A, Grace, J. M, Chescheir, G. M, Panda, S, Ouyang, Y, Sun, G, Vose, J. M

“…AbstractWe compared precipitation intensity-duration-frequency (PIDF) curves developed for four small forested watersheds to spatially interpolated estimates…”
Get full text

Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma by VOSE, J. M, LINK, B. K, GROSSBARD, M. L, CZUCZMAN, M, GRILLO-LOPEZ, A, GILMAN, P, LOWE, A, KUNKEL, L. A, FISHER, R. I

“…To determine the safety and efficacy of the combination of the chimeric anti-CD20 antibody Rituxan (rituximab, IDEC-C2B8; Genentech Inc, South San Francisco,…”
Get full text

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma by IQBAL, J, GREINER, T. C, HORSMAN, D. E, SHEN, Y, FU, K, WEISENBURGER, D. D, HANS, C. P, CAMPO, E, GASCOYNE, R. D, ROSENWALD, A, JAFFE, E. S, DELABIE, J, PATEL, K, RIMSZA, L, OTT, G, MÜLLER-HERMELINK, H. K, CONNORS, J. M, VOSE, J. M, MCKEITHAN, T, STAUDT, L. M, CHAN, W. C, DAVE, B. J, SMITH, L, JI, J, WRIGHT, G, SANGER, W. G, PICKERING, D. L, JAIN, S

“…Gene expression profiling of diffuse large B-cell lymphoma (DLBCL) has revealed biologically and prognostically distinct subgroups: germinal center B-cell-like…”
Get full text

Adjustments in hydraulic architecture of Pinus palustris maintain similar stomatal conductance in xeric and mesic habitats by Addington, R.N, Donovan, L.A, Mitchell, R.J, Vose, J.M, Pecot, S.D, Jack, S.B, Hacke, U.G, Sperry, J.S, Oren, R

“…We investigated relationships between whole-tree hydraulic architecture and stomatal conductance in Pinus palustris Mill. (longleaf pine) across habitats that…”
Get full text

Eddy covariance measurements with a new fast-response, enclosed-path analyzer: Spectral characteristics and cross-system comparisons by Novick, K.A., Walker, J., Chan, W.S., Schmidt, A., Sobek, C., Vose, J.M.

“…•Fluxes measured with a new closed-path analyzer show minimal spectral attenuation.•An analytical spectral correction approach is suitable for these flux…”
Get full text

Long-term hydrologic and water quality responses following commercial clearcutting of mixed hardwoods on a southern Appalachian catchment by Swank, W.T, Vose, J.M, Elliott, K.J

“…Long-term changes (∼20 years) in water yield, the storm hydrograph, stream inorganic chemistry, and sediment yield were analyzed for a 59 ha mixed hardwood…”
Get full text

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project by Suzumiya, J., Ohshima, K., Tamura, K., Karube, K., Uike, N., Tobinai, K., Gascoyne, R. D., Vose, J. M., Armitage, J. O., Weisenburger, D. D.

“…Background: The International Peripheral T-cell Lymphoma Project was organized to better understand the T-cell and natural killer (NK) cell lymphomas, and our…”
Get full text

A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma by Satwani, P, Ahn, K W, Carreras, J, Abdel-Azim, H, Cairo, M S, Cashen, A, Chen, A I, Cohen, J B, Costa, L J, Dandoy, C, Fenske, T S, Freytes, C O, Ganguly, S, Gale, R P, Ghosh, N, Hertzberg, M S, Hayashi, R J, Kamble, R T, Kanate, A S, Keating, A, Kharfan-Dabaja, M A, Lazarus, H M, Marks, D I, Nishihori, T, Olsson, R F, Prestidge, T D, Rolon, J M, Savani, B N, Vose, J M, Wood, W A, Inwards, D J, Bachanova, V, Smith, S M, Maloney, D G, Sureda, A, Hamadani, M

“…Autologous hematopoietic cell transplantation (AutoHCT) is a potentially curative treatment modality for relapsed/refractory Hodgkin lymphoma (HL). However, no…”
Get full text

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma by Bierman, P J, Vose, J M, Anderson, J R, Bishop, M R, Kessinger, A, Armitage, J O

“…This study evaluated the results of high-dose therapy followed by autologous bone marrow or peripheral-blood stem-cell transplantation for patients with…”
Get more information

Generality of leaf trait relationships. A test across six biomes by Reich, Peter B., Ellsworth, David S., Walters, Michael B., Vose, James M., Gresham, Charles, Volin, John C., Bowman, William D.

“…Convergence in interspecific leaf trait relationships across diverse taxonomic groups and biomes would have important evolutionary and ecological implications…”
Get full text

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas by KAMINSKI, Mark S, ZELENETZ, Andrew D, WAHL, Richard L, KNOX, Susan J, VOSE, Julie M, PRESS, Oliver W, SALEH, Mansoor, LEONARD, John, FEHRENBACHER, Louis, LISTER, T. Andrew, STAGG, Robert J, TIDMARSH, George F, KROLL, Stew

“…To evaluate the efficacy and safety of tositumomab and iodine I 131 tositumomab (Bexxar; Corixa Corp, Seattle, WA, and GlaxoSmithKline, Philadelphia, PA) in…”
Get full text

Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT) by Steuter, J A, Villanueva, M L H, Loberiza, F R, Armitage, J O, Bociek, R G, Ganti, A K, Tarantolo, S R, Vose, J M, Easley, A, Bierman, P J

“…The use of autologous hematopoietic SCT (auto-HSCT) has expanded to include older patients. Increasing age is a well-appreciated risk factor for the…”
Get full text

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion by Mian, M., Scandurra, M., Chigrinova, E., Shen, Y., Inghirami, G., Greiner, T.C., Chan, W.C., Vose, J.M., Testoni, M., Chiappella, A., Baldini, L., Ponzoni, M., Ferreri, A.J.M., Franceschetti, S., Gaidano, G., Montes-Moreno, S., Piris, M.A., Facchetti, F., Tucci, A., Nomdedeu, J.Fr, Lazure, T., Uccella, S., Tibiletti, M.G., Zucca, E., Kwee, I., Bertoni, F.

“…Deletions at 13q14.3 are common in chronic lymphocytic leukemia and are also present in diffuse large B-cell lymphomas (DLBCL) but never in…”
Get full text

Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared With Daily Filgrastim After Chemotherapy for Lymphoma by VOSE, J. M, CRUMP, M, LIANG, B. C, LAZARUS, H, EMMANOUILIDES, C, SCHENKEIN, D, MOORE, J, FRANKEL, S, FLINN, I, LOVELACE, W, HACKETT, J

“…The primary objective was to assess the duration of grade 4 neutropenia (neutrophil count < 0.5 x 10(9)/L) after one cycle of chemotherapy with etoposide,…”
Get full text

Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience by Ganti, A.K., Weisenburger, D.D., Smith, L.M., Hans, C.P., Bociek, R.G., Bierman, P.J., Vose, J.M., Armitage, J.O.

“…The aim of the study was to determine the outcome and clinical features predictive of survival in patients with follicular lymphoma (FL) treated aggressively…”
Get full text